Loading...
Loading...
Horizon Pharma, Inc.
HZNP today announced that the S-4 registration statement
filed by Vidara Therapeutics International Public Limited Company
("Vidara") with the Securities and Exchange Commission on June 26,
2014, as amended on July 28, 2014 and August 6, 2014 regarding the
proposed acquisition of Vidara through a reverse merger with Horizon
Pharma was declared effective by the SEC on August 7, 2014.
The Company also announced that Horizon has scheduled a special
meeting of its stockholders on Thursday, September 18, 2014 at 8:00
a.m. Central Time at the Company's headquarters at 520 Lake Cook
Road, Suite 520, Deerfield, Illinois. The meeting is being held to
seek stockholder approval in connection with the acquisition and
related matters. Horizon's stockholders of record as of the close of
business on July 30, 2014 are entitled to vote at the meeting. The
Company currently expects to complete the acquisition shortly
thereafter assuming stockholder approval is obtained, subject to
customary closing conditions.
Horizon expects to begin mailing a proxy statement/prospectus to
stockholders on or about August 11, 2014.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in